| Catalog No | Product Description | CAS No. | Purity | Structural Formula |
|---|---|---|---|---|
| SBP02918 |
Pellitorine
Pellitorine is a potential larvicide with a specific target site and a lead molecule for the control of mosquito populations, it also shows antiprotozoal activity against Plasmodium falciparum (IC50 = 3.3 ug/mL). Pellitorine shows potent antiplatelet aggregation activity, it can suppress expression of inducible NO synthase and cyclooxygenase-2. Pellitorine also shows strong cytotoxic activities against HL60 and MCT-7 cell lines. Pellitorine is a fatty amide. It has a role as a metabolite.
|
18836-52-7 | 98% |
|
| BP0999 |
N-Methylcytisine
N-Methylcytisine's nicotinic receptors have high affinity (KD = 50 nM)to nAChR from squid optical ganglia, N-methylcytisine is a selective ligand of nicotinic receptors of acetylcholine in the central nervous system. (−)-N-methylcytisine and (−)-anagyrine have nematicidal activity against pine wood nematodes.
|
486-86-2 | 98% |
|
| BP0491 |
Dihydroartemisinin
Dihydroartemisinin is widely used as an intermediate in the preparation of other artemisinin-derived antimalarial drugs, recommended as the first-line anti-malarial drug with low toxicity. Dihydroartemisinin has anticancer activity, it inhibited cell proliferation via AKT/GSK3β/cyclinD1/ERK pathway and induced apoptosis is associated with inhibition of Sarco/Endoplasmic reticulum Calcium ATPase activity in colorectal cancer.
|
71939-50-9 | 98% |
|
| BP0250 |
Berbamine Hydrochloride
Berbamine hydrochloride and Ver block the calcium-induced contraction of depolarized pig coronary artery strips, indicate that it may competitively antagonize the action of calcium.
|
6078-17-7 | 98% |
|
| BP5773 | 116159-73-0 |
|
||
| BP0329 | 5853-29-2 | 98% |
|
|
| BPF2224 |
Psoralenoside
Psoralenoside is a narture product from Psoralea corylifolia.
|
905954-17-8 | 98% |
|
| SBP02170 | 482-68-8 |
|
||
| BP1730 |
Cratoxylone
1. Cratoxylone exhibits potent activity in vitro against Plasmodium falciparum chloroquine-resistant strain W2, with the IC₅₀ value belows 3 uM.
|
149155-01-1 | 98% |
|
| BP2019 | 30485-16-6 | 98% |
|
|
| BPF2123 | 72755-19-2 | 98% |
|
|
| SBP03638 |
Asimilobine
(-)-Asimilobine shows antioxidative, anti-acetylcholinesterase (AChE), anti-α-glucosidase, anti-leishmanial and anti-fungal activities; it displays weak inhibition against Streptococcus mutans (ATCC 25175), with a minimum inhibition concentration (MIC) of 0.25 mg/mL.
|
6871-21-2 | 98% |
|
| SBP03451 |
Evocarpine
Evocarpine shows antimycobacterial, and vasorelaxant effects, it can inhibit Ca2+ influx through voltage-dependent calcium channels.
|
15266-38-3 | 98% |
|
| BP0264 |
Febrifugine
Febrifugine is an effective coccidiostat, possesses schizonticide props; it and its derivatives shows high degree of antimalarial activity but use limited by toxicity .
|
24159-07-7 | 98% |
|
| BP0383 | 546-97-4 | 98% |
|
|
| BP1581 |
Arteannuin B
Arteannuin B and artemisinic acid are biogenetic precursors of artemisinin, an important antimalarial produced by the herb Artemisia annua, they are active against different bacteria and certain fungal species. Arteannuin B has potential antimalarialand antitumor activity.
|
50906-56-4 | 98% |
|
| BP3086 |
Bevirimat
Bevirimat is a pentacyclic triterpenoid obtained by the formal condensation of 2,2-dimethylsuccinic acid with the 3-hydroxy group of betulinic acid. It is isolated from the Chinese herb Syzygium claviflorum. The first in the class of HIV-1 maturation inhibitors to be studied in humans, bevirimat was identified as a potent HIV drug candidate and several clinical trials were conducted, but development into a new drug was plagued by numerous resistance-related problems.
|
174022-42-5 | 98% |
|
| BP4823 | 1617-84-1 | 98% |
|
|
| BP0314 |
Carabrone
Some of carabrone derivatives exhibit antifungal activities in vitro or in vivo, the compounds with a pyridinyl residue can either efficiently inhibit spore germination or efficiently inhibit hyphal growth of B. cinerea.
|
1748-81-8 | 98% |
|
| BP3405 |
Yangambin
Yangambin is a selective antagonist of the cardiovascular effects of platelet activating factor (PAF); it has hypotensive effect, which is probably due to a peripheral vasodilatation that involves, at least, the inhibition the Ca2+ influx through voltage-gated Ca2+ channels. Yangambin has central nervous system activity, it presents a depressant activity in the open field, forced swimming and pentobarbital sleeping time tests.
|
13060-14-5 | 98% |
|
Shenshuai
Wenjing
Hedandan